Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Business Strategies
Brilliant BioPharma
Wyeth BioPharma is the fourth largest biotech company in the world, Cavan Redmond and Dr. Michael Kamarck talk to NGP’s Rebecca Goozee about challenges, collaborations and the future of biotechnology.
A Pragmatic Path to Enterprise Content Management
Ken Lownie and Tim May, Glemser Technologies explain how and why pharma companies are seeking to combine and consolidate sets of applications.
Managing maintenance (and much more)
Pharmaceutical and biotech companies are under unprecedented pressure to manage their costs more effectively. Look through the annual reports of the largest companies – many have made a commitment to deliver productivity benefits to their shareholder
Portfolio Management
Richard Sonnenblick, President of Enrich, John Howell, Founder and President of Portfolio Decisions and Dr. James Mattheson, Chariman and CFO of SmartOrg Inc. talk about maximizing profitability, achieving a balance and the ever-changing landscape of portfolio management.
Changing Business at Wyeth
Geno Germano, President – US and General Manager of Wyeth Pharmaceuticals, shares his insights around the drivers that have forced pharmaceutical companies to change their business model and how Wyeth has responded.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.